TELO
#4039
Telomir Pharmaceuticals, Inc. - Common Stock
1.1 9 USD
+0.02%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
+1.71%
Monatliche Änderung
0.00%
6 month change
-0.83%
Jahresänderung
-16.20%
Vorheriger Schlusskurs
1.1 7
Open
1.1 9
Tief
1.1 9
Hoch
1.1 9
Volumen
1
Financials
2025
Current report, Q4 FY2025
Telomir Pharmaceuticals, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Telomir Pharmaceuticals, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Telomir Pharmaceuticals, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Telomir Pharmaceuticals, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Telomir Pharmaceuticals, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Telomir Pharmaceuticals, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Telomir Pharmaceuticals, Inc. current report, Q4 FY2025
8-K
Quarterly report, Q3 FY2025
Telomir Pharmaceuticals, Inc. quarterly report, Q3 FY2025
10-Q
Current report, Q3 FY2025
Telomir Pharmaceuticals, Inc. current report, Q3 FY2025
8-K
Current report, Q3 FY2025
Telomir Pharmaceuticals, Inc. current report, Q3 FY2025
8-K